Your browser doesn't support javascript.
loading
Unexpected frequency of the pathogenic AR CAG repeat expansion in the general population.
Zanovello, Matteo; Ibáñez, Kristina; Brown, Anna-Leigh; Sivakumar, Prasanth; Bombaci, Alessandro; Santos, Liana; van Vugt, Joke J F A; Narzisi, Giuseppe; Karra, Ramita; Scholz, Sonja W; Ding, Jinhui; Gibbs, J Raphael; Chiò, Adriano; Dalgard, Clifton; Weisburd, Ben; Hanna, Michael G; Greensmith, Linda; Phatnani, Hemali; Veldink, Jan H; Traynor, Bryan J; Polke, James; Houlden, Henry; Fratta, Pietro; Tucci, Arianna.
Affiliation
  • Zanovello M; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, UCL, London WC1N 3BG, UK.
  • Ibáñez K; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.
  • Brown AL; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, UCL, London WC1N 3BG, UK.
  • Sivakumar P; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, UCL, London WC1N 3BG, UK.
  • Bombaci A; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, UCL, London WC1N 3BG, UK.
  • Santos L; 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin 10126, Italy.
  • van Vugt JJFA; Neurogenetics Unit, National Hospital for Neurology and Neurosurgery, London WC1N 3BG, UK.
  • Narzisi G; Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht 3508, The Netherlands.
  • Karra R; Center for Genomics of Neurodegenerative Disease, New York Genome Center, New York, NY 10013, USA.
  • Scholz SW; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA.
  • Ding J; Department of Neurology, Brain Sciences Institute, Baltimore, MD 21287, USA.
  • Gibbs JR; Department of Neurology, Brain Sciences Institute, Baltimore, MD 21287, USA.
  • Chiò A; Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
  • Dalgard C; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA.
  • Weisburd B; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA.
  • Hanna MG; Department of Anatomy, Physiology and Genetics, School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
  • Greensmith L; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MT 02142, USA.
  • Veldink JH; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, UCL, London WC1N 3BG, UK.
  • Traynor BJ; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, UCL, London WC1N 3BG, UK.
  • Polke J; Center for Genomics of Neurodegenerative Disease, New York Genome Center, New York, NY 10013, USA.
  • Houlden H; Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht 3508, The Netherlands.
  • Fratta P; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA.
  • Tucci A; Department of Neurology, Brain Sciences Institute, Baltimore, MD 21287, USA.
Brain ; 146(7): 2723-2729, 2023 07 03.
Article in En | MEDLINE | ID: mdl-36797998
CAG repeat expansions in exon 1 of the AR gene on the X chromosome cause spinal and bulbar muscular atrophy, a male-specific progressive neuromuscular disorder associated with a variety of extra-neurological symptoms. The disease has a reported male prevalence of approximately 1:30 000 or less, but the AR repeat expansion frequency is unknown. We established a pipeline, which combines the use of the ExpansionHunter tool and visual validation, to detect AR CAG expansion on whole-genome sequencing data, benchmarked it to fragment PCR sizing, and applied it to 74 277 unrelated individuals from four large cohorts. Our pipeline showed sensitivity of 100% [95% confidence interval (CI) 90.8-100%], specificity of 99% (95% CI 94.2-99.7%), and a positive predictive value of 97.4% (95% CI 84.4-99.6%). We found the mutation frequency to be 1:3182 (95% CI 1:2309-1:4386, n = 117 734) X chromosomes-10 times more frequent than the reported disease prevalence. Modelling using the novel mutation frequency led to estimate disease prevalence of 1:6887 males, more than four times more frequent than the reported disease prevalence. This discrepancy is possibly due to underdiagnosis of this neuromuscular condition, reduced penetrance, and/or pleomorphic clinical manifestations.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Muscular Atrophy, Spinal / Receptors, Androgen Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Muscular Atrophy, Spinal / Receptors, Androgen Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Year: 2023 Type: Article